Key Takeaways from the FDA’s Review of CBD Products for Mislabeling and Adulteration
FDA recently sent an overdue report to Congress regarding its review of CBD products for mislabeling and adulteration... The U.S. Food and Drug Administration (FDA) recently sent an overdue report to Congress regarding its review of cannabidiol (CBD) products for mislabeling and adulteration. The FDA report revealed that mislabeling and adulteration...